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Cardiac actin is an early marker of cardiac and skeletal muscle lineages in the mouse. After birth, the gene is down-
regulated in skeletal muscle. High-level expression of the murine cardiac actin gene in skeletal myotubes in vitro involves
distal (07.8/07.0 kb) and proximal (05.4/03.5 kb) enhancer sequences as well as the proximal promoter (00.7//0.1 kb).
Transgenic mice carrying an nlacZ reporter gene under the control of different fragments of the upstream region of the
cardiac actin gene were generated. This analysis led to the conclusions that (1) the proximal promoter is a weak but tissue
speci®c element in vivo, (2) consistent high-level expression in skeletal muscle depends on the presence of at least one of
the enhancers, (3) expression in adult cardiac muscle requires a cardiac enhancer located in the (05.4/00.7 kb) region, and
(4) a construct containing these three elements gives a strong speci®c expression of the transgene in the heart throughout
the life of the animal and in embryonic skeletal muscle. All transgenes tested reproduce the down-regulation observed in
adult skeletal muscle for the cardiac actin gene. Nonuniform expression of these transgenes in the heart may mark
cardiomyocytes derived from different cardiac progenitors. q 1996 Academic Press, Inc.
INTRODUCTION and Buckingham, 1992). Although many of the proteins ex-
pressed on differentiation are the same, skeletal and cardiac
Muscle tissues can be divided into two groups, smooth myogenesis differ in a number of important respects. During
and striated muscle; the latter group comprising skeletal embryogenesis, the two tissues have a different mesodermal
and cardiac muscle. These tissues express actins, myosin origin: skeletal muscle derives from paraxial and the heart
light and heavy chains, and other components of the con- from lateral mesoderm (see Kaufman, 1992). In mouse em-
tractile apparatus. Most of these proteins exist as different bryos, the ®rst muscle markers are detectable in the cardiac
isoforms which are encoded by different genes or result from tube from about 7.5 days post coitum (p.c.) (Sassoon et al.,
alternative splicing; one isoform usually predominates in a 1988; Lyons et al., 1990; Edmondson et al., 1994). Subse-
particular type of muscle, for instance, skeletal actin is the quently, the tube turns and, after a few days, septation is
main isoform in adult skeletal muscle, as cardiac actin is completed. During this period, expression of myosin genes,
in the heart. However, very few genes are strictly restricted for example, begins to be restricted to atria or ventricles
to one type of striated muscle throughout the life of the (Lyons et al., 1990). In comparison with the heart, skeletal
animal; for example, cardiac and skeletal actins are coex- myogenesis is initiated rather later. Somites, which give
pressed in embryonic cardiac and skeletal muscle (see Lyons rise to myogenic precursors, appear from 8 days p.c. and the
myotome, the ®rst skeletal muscle mass to form in the
trunk of the embryo, expresses muscle markers from 8.51 Current address: The Walter & Eliza Hall Institute, Post Of®ce,
days p.c. (see Lyons and Buckingham, 1992). PeripheralRoyal Melbourne Hospital, 3050 Victoria, Australia.
2 To whom correspondence should be addressed. muscles, such as those in the hind limb, begin to differenti-
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ate from about 11.5 days p.c. (Ontell et al., 1993). Undiffer- (Lyons et al., 1991) and decline together in the latter when
it matures (Vandekerckhove et al., 1986).entiated skeletal muscle myoblasts (satellite cells) continue
The proximal promoter of the cardiac actin gene directsto be present in mature muscle which retains the potential
expression of a reporter gene in cultured muscle cells, into regenerate (Ontell, 1975), whereas in the heart this is not
both cardiomyocytes and skeletal myotubes when they dif-the case. In contrast to skeletal myoblasts, cardiomyocytes
ferentiate from myoblasts. Transcriptional activation in dif-do not fuse into ®bers, and mononucleated differentiated
ferentiating skeletal muscle cells depends critically on ancells can divide in the embryo (see Litvin et al., 1992). The
SP1 site, a CArG-box binding SRF, and an E-box bindingtwo tissues also differ signi®cantly at the molecular level
members of the MyoD family (Sartorelli et al., 1990). Thein their content of transcriptional regulatory proteins. In
same sites are implicated in cardiomyocytes, although theskeletal muscle, the MyoD family of helix-loop-helix pro-
importance of the E-box is controversial (Sartorelli et al.,teins regulates the transcription of many muscle-speci®c
1992, Skerjanc and McBurney, 1994). Analysis of the pheno-genes (see Weintraub et al., 1991). Mutation of these genes
type of the BALB/C mouse, in which cardiac actin transcrip-in the mouse has demonstrated the importance of myogenin
tion is perturbed in both skeletal and cardiac muscle (Gar-for muscle cell differentiation and of MyoD and myf5 for
ner et al., 1986, 1989), led to the isolation of two muscle-the precursor myoblast populations (see Buckingham,
speci®c enhancers at 07.0 and 05.0 kilobases (kb) from the1994). This family of transcription factors is not present in
transcription start site of the gene (Biben et al., 1994). Inthe heart, nor in smooth muscle, at any stage of develop-
cultures of differentiating skeletal muscle cells each en-ment. Conversely, some cardiac transcription factors are
hancer increases the activity of a heterologous or a homolo-not expressed in skeletal muscle. An example is provided
gous promoter by at least 60-fold. Molecular analysis of theby GATA-4, which is speci®cally present in the myocar-
distal enhancer (Biben et al., 1994) has demonstrated thatdium and in some endothelial tissues (Arceci et al., 1993;
its function depends on an E-box binding the MyoD familyGreÂpin et al., 1994), and has been shown to be required for
of proteins and on a second site recognized by a complexthe transcription of a number of cardiac genes (see GreÂpin
containing Oct1 (B. Kirschbaum and C. Biben, unpublishedet al., 1995). Another example is provided by the homeobox
results). The role of these enhancers in cardiomyocytes isprotein Nkx2-5 (Lints et al., 1993), also called CSX (Komuro
unknown. In order to test their activities in cardiac andand Izumo, 1993), a mammalian homologue of the tinman
skeletal muscle in vivo we carried out transgenic experi-gene, which is essential for heart formation in Drosophila
ments where transcription of an nlacZ (nuclear targeted b-(Bodmer, 1993). Inactivation of Nkx2-5 in mice does not
galactosidase) reporter gene was under the control of differ-prevent heart formation but interferes with ventricular de-
ent fragments of the upstream region of the mouse cardiac
velopment and morphogenesis (Lyons et al., 1995). Other
actin gene. The results obtained lead to the conclusion that
factors which play an important role in the regulation of
the transcription of this gene is under the control of at least
muscle-speci®c genes are common to both types of striated three elements: a weak but muscle-speci®c proximal pro-
muscle. This is the case for the MEF2 or RSRF (Related moter, a distal enhancer which functions in embryonic skel-
Serum Response Factor) family (see Martin et al., 1994; Ed- etal muscle, and a second more proximal enhancer essential
mondson et al., 1994). In Drosophila, mutation of the for expression in the adult heart.
unique MEF2 gene (D-MEF2) abolishes differentiation of
cardiac, skeletal, and visceral muscles, showing that in the
¯y, the myogenic program has a key regulator in common MATERIAL AND METHODS
(Lilly et al., 1995).
The cardiac actin gene is expressed in skeletal and cardiac Construction of Transgenes
muscles of the mouse as soon as they differentiate. Tran-
The ®rst intron of the murine cardiac actin gene was cloned byscripts are detected in the 7.8-day-p.c. mouse embryo in the
PCR (Polymerase Chain Reaction) using oligonucleotides comple-early myocardium and in somites from 8.5 days p.c. as the
mentary to the 5* end of the ®rst intron and the second exon (under-
myotome begins to form (Sassoon et al., 1988). After birth lined regions): intron 1: 5*-GAATTCAGATCTGGATCCCAC-
the gene is down-regulated in skeletal muscle but tran- ACTCTTAGTTTTG-3* and exon 2: 5*-CTTCGAATTCAGATC-
scripts are still detectable, representing 5% of the total mus- TCCATGGTGGTCTCCTCGTCGTCACA-3* as primers and the
cle actin mRNAs (Garner et al., 1989). Expression remains original l IG10 phage as a template (Garner et al., 1986). The frag-
ment (from /119 to the 8th amino acid of the coding sequencestrong in the myocardium. Nuclear run-on experiments
located in the second exonÐabout 750 bp) was digested with EcoRIhave shown that this gene is mainly regulated at the level
and BamHI and cloned into Bluescript (pSK) (Stratagene) cut withof transcription in differentiating skeletal muscle cells (Cox
the same enzymes, generating pACPC16. The nlacZ 3.4-kb frag-et al., 1990). Attempts to examine this in vivo have indi-
ment was prepared by incubating the pSDKNLSlacZ vector (S. Taj-cated that the cardiac actin gene is repressed in postnatal
bakhsh et al., in preparation) with (1) BamHI, (2) Klenow fragment,
skeletal muscle (Cox and Buckingham, 1992). There is no (3) NcoI, and subsequently subcloned into pACPC16 treated with
evidence of posttranscriptional regulation in the pattern of (1) EcoRI, (2) Klenow fragment, (3) NcoI to construct pAC1SDK-
expression of the protein and the messenger RNA which nlacZ1. A 2.4-kb BamHI fragment from IG41 derived from l IG10
(Garner et al., 1986) containing the (02.3//0.119 kb) region of thecoaccumulate in the embryonic heart and skeletal muscle
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murine cardiac actin gene was inserted into the 5* BamHI site of bridization at 657C in 50 mM Na2HPO4 (pH 7.6), 51 SSC, 51 Den-
hardt, 0.1% SDS, 100 mg/ml salmon sperm DNA. Filters werepAC1SDKnlacZ1 generating pAC2.4nlacZ.
The T1 transgene was generated by inserting the XbaI±BamHI washed in 0.11 SSC, 0.1% SDS at 657C. Probes (recognizing the b-
galactosidase sequence or 5* regions of the cardiac actin gene) werefragment of POX (Biben et al., 1994) containing the 00.66//0.119-
kb promoter fragment into pAC2.4nlacZ digested with BamHI and labeled using the Amersham megaprime RPN 1606 random prim-
ing kit and puri®ed on a nuctrap push-column (Stratagene).XbaI (partial) in place of the 02.3//0.119-kb fragment. The same
strategy was used for cloning the T2 transgene by inserting the Most transgenic lines contained a few copies of the transgene
(1±5). However, certain lines (e.g., T4-296) had much higher copyXbaI±BamHI fragment of 1P (containing the distal enhancer (08.1/
05.6 kb) juxtaposed to the (00.66//0.1 kb) proximal promoter) numbers (⁄50) and b-galactosidase levels were correspondingly
higher in these lines.(Biben et al., 1994) into pAC2.4nlacZ.
To generate the T4 transgene, the (09.0/0.66 kb) BamHI±EcoRI
fragment of the cardiac actin promoter was cloned from the original
Analysis of the Transgene Expression(l 5) phage (Biben et al., 1994) as follows: the (05.4/00.66 kb)
BamHI±EcoRI fragment was ®rst subcloned into Bluescript (Stra-
Matings. b-Galactosidase expression was assayed in embryos
tagene) (pLEB) and the (09.0/05.4 kb) BamHI fragment was inserted
and older mice from crosses between F1 transgenic males and
into pLEB to generate pLEBB. To generate pAC9nlacZ, the T4
(C57BL/6J 1 CBA) F1 females. Noon of the day of the plug was
transgene, a three-part ligation was carried out using pLEBB di-
considered 0.5 days post coitum (d.p.c.). Transgenic embryos were
gested with XhoI/EcoRI (09.0/00.66 kb), pAC2.4nlacZ digested
identi®ed from wild type by PCR analysis on DNA extracted, as
with BamHI/XhoI, and pIG41 digested with EcoRI/BamHI (00.66/
described for the tails, from a small portion of the embryo after/0.119). This strategy was adopted to include the additional EcoRI
staining. At later stages DNA was prepared from tail biopsies.
site present in the promoter of the cardiac actin gene in C3H mice
Fixation and X-Gal staining. Embryos were dissected in PBS1X(see Biben et al., 1994). The T3 transgene was generated by a partial
and ®xed in 4% paraformaldehyde at room temperature for 10±20BamHI digestion to eliminate the 09.0/05.4-kb fragment from
min (8.0±8.5 d.p.c.), 30±45 min (9.0±10.0 d.p.c.), 1±1.5 hr (11.0±pAC9nlacZ.
12.0 d.p.c.), 1.5±3 hr (13.0±14.0 d.p.c.). Older embryos were ®xed
for 2 hr and then cut in two and re®xed. Isolated organs (hearts or
skeletal muscles) were ®xed for 10 to 30 min depending on the sizeConstruction of Transgenic Lines
of the tissue.
Puri®cation of the injected fragments. Transgenes were linear- Fixed embryos were washed three times in PBS1X and incubated
ized with XhoI and SacII for T1, T2, and T4 and with HindIII for overnight at 327C in 4 mM potassium ferricyanide, 4 mM potassium
T3. They were electroeluted from an agarose gel and subsequently ferrocyanide, 2 mM magnesium chloride, 0.4 mg/ml X-Gal, 0.02%
puri®ed on an Elutip-d column (Cera-Labo). DNA was then precipi- NP-40 in PBS1X (Sanes et al., 1986). Isolated adult hearts from T3
tated with ethanol, rinsed, and resuspended in Brinster buffer (see and T4 transgenic lines were stained for 2 hr. In some cases where
Hogan et al., 1986). DNA concentrations were estimated on gels multiple copies of the transgene were present, shorter incubation
and fragments diluted to 500 copies/picoliter. times were used for embryos and isolated hearts. Transgenic em-
Injection procedure. The protocol used was as described in Ho- bryos and individual muscles were analyzed by whole mount mi-
gan et al. (1986), with the exception that (C57BL/6J 1 SJL) F1 mice croscopy.
were used to provide oocytes. Embryos were reimplanted into
pseudo-pregnant (C57BL/6J 1 CBA) F1 foster mothers.
RESULTS
Screening of the Transgenic Mice
Construction of the TransgenesGenomic DNA preparation (based on Laird et al., 1991). A
0.5- to 1.0-cm tail biopsy was digested in 0.5 ml of lysis buffer (100 All the transgenes (see Fig. 1) encode the Escherichia coli
mM TrisrHCl, pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 200 b-galactosidase enzyme targeted to the nucleus by the fu-
mg/ml Proteinase K) overnight at 557C. After 10 min centrifugation sion of a nuclear localization signal (n) (Kalderon et al.,
(13,000 rpm), the supernatant was poured into 500 ml of isopropa-
1984), which facilitates the detection of speci®c versus non-nol. The precipitate that formed on shaking was collected with a
speci®c lacZ expression at the cellular level. The basal con-yellow Gilson tip and washed in 80% ethanol for 1 min, centri-
struction is T1 which contains the nlacZ transgene fusedfuged, dessicated, and resuspended in 100 ml H2O for 1 hr at 407C.
to the translational initiation codon ATG present in thePolymerase chain reaction. A 260-bp fragment of the b-galac-
tosidase N-terminal sequence was ampli®ed using the following second exon of the mouse cardiac actin gene. Transcription
primers (O1: 5*-GTCGTTTTACAACGTCGTGACT-3*, O2: 5*- of this chimeric gene is under the control of the proximal
GATGGGCGCATCGTAACCGTGCA-3*). One microliter of a promoter (00.66 kb) of the cardiac actin gene. This promoter
one-®fth dilution of the above DNA preparation was incubated fragment was used as the reference construct in most of the
with 100 ng of each primer in 10 ml for 5 min at 947C. Ten microli- transfection experiments described in Biben et al. (1994).
ters of (0.4 mM dNTPs, 21 Taq polymerase buffer, 0.5 units Taq The ®rst exon and intron together with part of the second
polymerase (Amersham)) was added. The reaction was carried out
exon containing the ATG of the gene (0.8 kb) were retainedfor 28 cycles (947C, 45 sec; 557C, 1 min; 727C, 2 min).
to avoid interference with normal translational control. TheSouthern blots. Ten microliters of the DNA preparation was
T2 transgene has, in addition, a 1.9-kb fragment containingdigested with different restriction enzymes (depending on the
the distal enhancer which in transfection experiments intransgene and the probe used) and transferred to a Hybond N/ mem-
brane (Amersham) following standard procedures for overnight hy- cultured muscle cells enhances the transcription of the ho-
Copyright q 1996 by Academic Press, Inc. All rights of reproduction in any form reserved.
/ m4592f8102 12-18-95 09:11:17 dba Dev Bio
203Regulation of Cardiac Actin
FIG. 1. The left side of the ®gure shows a schematic representation of the different transgenes, in relation to the endogenous cardiac
actin gene shown in the top line. Regulatory elements in the 09-kb sequence upstream of the cap site ( ) are indicated above the line
as follows: … distal enhancer (ED),
 
 proximal enhancer (EP), and É proximal promoter. The ®rst exon and part of the second exon
containing the ATG of the cardiac actin gene are indicated as . The line between exons corresponds to the ®rst intron of the gene. The
transgene is indicated as h for the nuclear localization signal (n) and for the b-galactosidase coding sequence (lacZ). The right side of
the ®gure shows the total number of transgenic lines obtained ( ), preceded by the number which expressed the transgene. The following
columns present a schematic representation of the expression pro®les obtained in striated muscle with the different types of transgene
compared with that of the endogenous gene shown in the ®rst line. SM, skeletal muscle; CM, cardiac muscle; embryo, 10.5 days p.c.;
adult, 2 months. Absolute levels of expression varied due to the effects of position and copy number. Such quantitative considerations,
together with ectopic sites of expression, are discussed in the text. In the table, / indicates extensive b-galactosidase staining in the
muscle; { indicates that occasional cells or ®bres are stained.
mologous promoter by about 60-fold. This sequence (ED) of 1±10. Exceptions are indicated in the description of each
type of transgene which follows. Integration effects, whichalso enhances muscle-speci®c transcription of the thymi-
dine kinase (TK) gene promoter in differentiated muscle also lead to variation in the absolute levels of expression in
striated muscle and to ectopic expression, are also dis-cells (190) (Biben et al., 1994). The T3 transgene contains
a (05.4//0.8 kb) fragment, including the proximal enhancer cussed.
(05.4/03.5 kb) which acts as an enhancer increasing the
level of muscle-speci®c transcription from the TK promoter
The Proximal Promoter Is Weak but Speci®c inby a factor of 60 (Biben et al., 1994). T4 is the largest con-
Vivostruct with both enhancers and all the sequences contained
from 09.0 to /0.8 kb in the mouse cardiac actin gene. Of the seven T1 lines in which transgene expression is
under the control of the proximal promoter, only two gaveAnalyses of transgene expression were carried out with
established mouse lines (heterozygote (C57BL/6J 1 SJL) F1 a detectable b-galactosidase activity. In both lines skeletal
muscle expresses the transgene during embryogenesis (Fig.males, crossed with (C57BL/6J 1 CBA) F1 females). Seven
lines were generated with the T1 construct, 5 with T2, 11 2A). The ®rst blue nuclei begin to accumulate in the myo-
tomes around the 17- to 20-somite stage and most of skele-with T3, and 6 with T4. The numbers of expressing lines
and a schematic representation of the expression patterns tal muscle masses are labeled as the embryo develops. In
the adult only a few muscle ®bers are still weakly labeledobtained with each transgene in striated muscle are shown
in Fig. 1. Most transgenes were present with a copy number (see later). Only one line has a uniformly high level of ex-
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FIG. 2. Expression of nlacZ in transgenic lines with the proximal promoter (T1) or the promoter and distal enhancer (T2) of the mouse
cardiac actin gene. (A) A 10.5-d.p.c. T1 embryo showing b-galactosidase staining in the heart (H), dorsal aorta (DA), and skeletal muscle
of the myotome (M). The arrowheads indicate weak ectopic expression in cranial ganglia. (B) A 15.5-d.p.c. T2 embryo showing b-galactosi-
dase staining in skeletal musculature. (C) An adult T1 heart showing that the bulk of the myocardium is not stained with b-galactosidase.
(D) The heart of a 10.5-d.p.c. T2 embryo showing no b-galactosidase staining in the ventricles (V) and out¯ow tract (OT). A few labeled
cells are present in the atria (A).
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pression initially in the embryonic heart, the other having galactosidase activity in embryonic skeletal muscle (Fig.
2B). However, in these lines the heart contains only a fewa more ``patchy'' expression pattern. However in both cases
expression begins when expected, as soon as the cardiogenic blue nuclei mainly located in the atria and between the
ventricles (Fig. 2D) and this is true in the embryo as wellplates differentiate (result not shown). By 10.5 days p.c. in
the line with a higher level of expression in the heart, b- as in the adult mouse. This is in contrast to the two T1
expressing lines. Since copy numbers were comparable (2±galactosidase labeling is already weaker in the out¯ow tract
(Fig. 2A). In both lines the dorsal aorta (Fig. 2A) is also 10), we conclude that the distal enhancer, unlike the puta-
tive enhancer elements at the site of integration of the T1labeled; this re¯ects the pattern of expression of the endoge-
nous gene as described by in situ hybridisation (Sassoon et transgene, does not increase the activity of the cardiac actin
promoter in the embryonic heart; in addition, it buffers theal., 1988). In the adult heart only occasional blue nuclei are
detectable, located in the innermost part of the myocardium proximal promoter against such context effects (see Discus-
sion). Expression in adult skeletal muscle is again restricted(Fig. 2C).
Since ®ve of seven lines do not express the transgene the to a few ®bers (see later). In most of the mice as well as in
two sterile founder mice, there is expression in some bloodproximal promoter can be considered as a weak transcrip-
tional element. In the two expressing lines, some sites of vessels, in coronary arteries and blood vessels in the lung
(results not shown). This does not correspond to a system-ectopic expression were noted. While some of these were
not common to both lines and are therefore probably due atic expression in smooth muscle since many vessels are
not labeled. This pattern of expression was not observedto integration site effects on the weak promoter, a position
independent staining in the trigeminal and facial-accoustic with the T1 mice and is presumably due to elements present
in the distal enhancer.ganglia detectable from 9.5 days p.c. was observed with all
constructs (T1 to T4) in expressing lines (see Fig. 3A). We These results show that the distal enhancer is a dominant
element since most of the lines express the transgene in aconclude that this is due to sequences present within the
proximal promoter. reproducible way. It is active in skeletal muscle in vivo, but
does not drive a detectable level of expression in the vastIn the case of the two expressing lines, which had a simi-
lar copy number to those of nonexpressing lines, we assume majority of cardiac cells.
that the ability of the proximal promoter to direct transcrip-
tion is enhanced as a consequence of sequences surrounding A Cardiac Enhancer Located between 05.4 andthe integration site; it is active in the tissues where the 00.66 kb Is Required for High-Level Expression inendogenous gene is expressed, in a regulated fashion in the
the Heartembryo. Expression in the adult mouse is much weaker in
both cardiac and skeletal muscle. Whereas in skeletal mus- Seven of the 11 transgenic lines carrying T3 in which
transgene expression is under the control of the proximalcle this was expected based on the activity of the endoge-
nous gene, this result indicates that maintenance of tran- promoter and an additional 05.4 kb of upstream sequence
have extensive b-galactosidase staining in skeletal muscle,scription in the heart requires additional elements.
in keeping with the presence of a muscle-speci®c enhancer,
the proximal enhancer (Fig. 3A). Again, this shows down-
The Distal Enhancer Is Active in Skeletal but Not regulation in the adult (result not shown). The myocardium
Cardiac Muscle in Vivo is now strongly labeled in the embryo and also in the adult
for 6 of these lines (Figs. 3B and 3C). No staining was ob-Of the ®ve lines containing the T2 transgene where ex-
pression is under the control of the proximal promoter and served in blood vessels, but the blood of 3 of these 6 lines
shows expression of the nlacZ transgene in the embryo be-the distal enhancer element, four have high levels of b-
FIG. 3. Expression of nlacZ in T3 transgenic embryos with 05.4 kb of upstream 5* ¯anking sequence, including the promoter and
proximal enhancer of the mouse cardiac actin gene. (A) A 10.5-d.p.c. embryo showing b-galactosidase staining in the heart (H) and skeletal
muscle of the myotome (M). Ectopic expression is seen in cranial ganglia (arrowheads) and in blood (B) for 3 lines of 6. (B) The cardiac
tube (H) of an 8.5-d.p.c. embryo from a line which did not show nlacZ expression in blood, demonstrating that the embryonic myocardium
is highly stained with b-galactosidase. (C) An adult heart, cut in half, showing strong b-galactosidase staining; A, atria, LV, left ventricule.
FIG. 4. Expression of nlacZ in the skeletal muscle of transgenic embryos with 09 kb of 5* ¯anking sequence from the mouse cardiac
actin gene, including the promoter and proximal and distal enhancer elements (T4). (A) A 12.5-d.p.c. embryo showing strong b-galactosidase
staining in skeletal muscle masses. LM, limb muscle; AM, axial musculature. (B) Skeletal muscle dissected from the forelimb of a 13.5-
d.p.c. embryo showing high-level expression of b-galactosidase. (C) A subset of ®bers in the adult extensor digitalis longis (EDL) fast
skeletal muscle show b-galactosidase staining in nuclei. (D) In the adult soleus a slow skeletal muscle, no b-galactosidase staining of
®bers is seen, except for very rare weakly labeled nuclei indicated by the arrow. (E) In the adult diaphragm, ®bers are also negative. (F) In
the adult EDL, at lower magni®cation than C, the overall staining is weak compared with G, which shows an equivalent ®eld from the
adult EDL of a transgenic mouse (3F-nlacZ-E) in which the same reporter gene is controlled by regulatory sequences from a fast myosin
light chain gene (Kelly et al., 1995).
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tween 8.0 and 12.5 days p.c., probably in red blood cells DISCUSSION
since these become enucleated with consequent loss of any
nuclear targeted lacZ transgene, at about the time when b- The transgenic experiments reported here show that the
galactosidase labeling begins to decrease in the blood. Inter- expression of the mouse cardiac actin gene in vivo is under
estingly, the staining in the heart tends to be asymmetrical the control of at least three elements: a weak, but speci®c
(see next section). proximal promoter showing some expression in embryonic
We conclude that a regulatory element present in T3, but cardiac and skeletal muscle, and two upstream enhancer
not in T1 or T2, stimulates transcription and is required for sequences, the distal enhancer which functions in embry-
expression in the adult heart. onic skeletal muscle and a proximal enhancer essential for
expression in the adult heart.
The 09.0 to /0.8-kb Region Is Suf®cient for
Regulated Position-Independent nlacZ Expression
The Proximal Promoterin Cardiac and Skeletal Muscle
Six of six lines express the T4 transgene, which contains Only two of seven transgenic lines express the T1
transgene, and these two lines show sites of ectopic expres-09.0 kb of upstream ¯anking sequence, in cardiac and skele-
tal muscle in the embryo (Fig. 4A), with the expected early sion in addition to expression in striated muscle, indicating
that the promoter is weak and subject to position effects. Allonset of expression. These lines also show high level expres-
sion in the adult heart and down-regulation in adult skeletal expressing lines, with or without the upstream enhancers,
show b-galactosidase activity in the trigeminal and facial-muscle, as expected from the expression pattern of the en-
dogenous gene. Of the six T4 lines, one had a higher copy accoustic ganglia. There is no evidence that the endogenous
gene is expressed here (Sassoon et al., 1988; Lyons et al.,number (50 copies of the transgene), and striated muscle
stained intensely blue with standard b-galactosidase incu- 1991), although a low level of transcription may have been
missed, and it is more probable that in the transgenic con-bation times. However, when these were reduced, the rela-
tive differences between adult and embryonic skeletal mus- structions a regulatory element is unmasked in the proxi-
mal promoter which directs expression to these sites. Thecle were revealed. In adult skeletal muscle of the T4 lines,
as with the other transgenes (T1±T3), the tissue is much proximal promoter clearly contains regulatory elements re-
quired for activation of the gene in skeletal muscle duringless strongly labeled than in the embryo or neonate. The
adult extensor digitalis longus (EDL), a fast muscle, shows embryogenesis. Similarly, the proximal promoter of the car-
diac actin gene in Xenopus has been demonstrated to con-only very weak staining (Fig. 4F), compared with limb mus-
cle from a 12.5-d.p.c. T4 transgenic embryo (Fig. 4B) or adult tain the necessary regulatory elements for activation in
skeletal muscle cells after mesoderm induction (Mohun etEDL under similar staining conditions and at an equivalent
magni®cation from a transgenic mouse (3F-nlacZ-E; Kelly al., 1986). In adult skeletal muscle in the mouse, the T1
transgene is down-regulated, re¯ecting the expression of theet al., 1995) where the nlacZ reporter is under the control
of regulatory sequences from a fast myosin light chain gene endogenous gene (Garner et al., 1989). As in the case of the
other cardiac actin transgene constructions, residual expres-(Fig. 4G). At higher magni®cation, a subset of ®bers in the
adult EDL of T4 transgenic mice shows b-galactosidase sion is particularly low in the soleus muscle and the dia-
phragm where only some ®bers are weakly labeled. In faststaining in nuclei (Fig. 4C). In the adult soleus, a slow mus-
cle, and in the diaphragm, ®bers appear b-gal negative (Figs. muscles labeling is more easily detectable, with a regional
distribution suggesting overall reduced expression but4D and 4E); only very occasional blue nuclei can be detected
(e.g., Fig. 4D). maintenance in some ®ber types. Since the adult mouse
soleus muscle is mainly composed of type I and IIA ®bersTransgene expression tends to be asymmetrical in the
adult heart and this was the case for both the T3 and T4 (Lewis et al., 1982) and the diaphragm of type I and IIX
(Zardini and Parry, 1994), whereas the fast muscles exam-transgenics (Figs. 5A and 5B). Figure 5B shows a striking
example of this where the right ventricle is unlabeled. In ined contain mainly IIB ®bers, this suggests that IIB ®bers
continue to express low levels of the transgene. The occa-addition, where the atria are concerned, asymmetry is some-
times detected, with lower labeling in the left atrium (Fig. sional labeled ®bers in the soleus muscle and diaphragm
may be type IIA or IIX; alternatively, they may be rare IIB5B). In lines which show asymmetry, the phenomenon is
detectable in the embryonic heart before the onset of septa- ®bers which had been missed in these mouse tissues in
previous reports. The transgene, therefore, is down-regu-tion (Fig. 5C). No labeling of blood cells was seen with the
T4 transgene, but some blood vessels are labeled as observed lated in all ®ber types, but the residual expression is some-
what higher in fast ®bers, probably more markedly in IIBwith the T2 construct (results not shown).
The fact that T4 containing lines express the transgene type ®bers. The contrary might have been expected since
a number of genes expressed in the heart are speci®callyin a reproducible and regulated fashion shows that this con-
struct has a dominant, position-independent activity, re- expressed in adult slow skeletal muscle ®bers (see Bucking-
ham, 1990). It is unlikely that transgene expression in fastsulting in an expression pattern similar to that of the endog-
enous gene. IIB ®bers is due to the lacZ reporter; transgenic mice with
Copyright q 1996 by Academic Press, Inc. All rights of reproduction in any form reserved.
/ m4592f8102 12-18-95 09:11:17 dba Dev Bio
208 Biben et al.
a lacZ reporter gene under the control of the Pgk-1 promoter
have b-galactosidase activity in skeletal muscle, but not in
type IIB ®bers (McBurney et al., 1994). No information is
available on the residual activity of the endogenous cardiac
actin gene in different ®ber types. This is of the order of
3% of total a-actin (cardiac and skeletal) transcription as
detected by Northern analysis (Garner et al., 1989); such
low levels make this dif®cult to examine by in situ tech-
niques. In contrast, detection of b-galactosidase activity is
extremely sensitive, and furthermore, the nuclear localiza-
tion sequence concentrates the signal in the nucleus.
The proximal promoter can also direct transgene expres-
sion to the early embryonic heart, where b-galactosidase
activity is more or less extensive depending probably on
the enhancer properties of adjacent sequences at the site of
integration of the transgene, since copy numbers are simi-
lar. However the myocardium is not labeled in the adult,
clearly indicating that additional regulatory elements are
necessary for expression in the adult heart.
A recent paper (Dunwoodie et al., 1994) describing
transgenic experiments using either CAT or the human car-
diac actin gene sequence as a reporter, under the control
of ¯anking sequences from the human cardiac actin gene,
reports rather different results. The majority of the lines (32
of 41) expressed the transgene and expression remained high
in the adult heart. Although the overall level of expression
in striated muscle was lower than with 5.7 kb of 5* ¯anking
sequence, this was also seen with an 800-bp promoter frag-
ment. The human and mouse promoter sequences are very
similar in the proximal (0485 bp) region (Minty and Kedes,
1986), and levels of activity in transfection assays with the
mouse C2 muscle cell line are also comparable (Daubas et
al., 1988; Minty and Kedes, 1986). The cardiac actin pro-
moter in cultured muscle cells, like the myosin MLC3F
promoter (Kelly et al., 1995), requires enhancer elements to
reach high levels of activity (Biben et al., 1994). The activity
of the mouse cardiac actin promoter in cardiac cell cultures
has not yet been examined but the human promoter is ac-
tive both in primary cultures from fetal rat hearts (Sartorelli
FIG. 5. Expression of nlacZ in the hearts of T3 and T4 transgenic
mice in which the promoter and proximal enhancer sequence (05.4
kb) are present in both transgenes. (A) An adult T3 heart shows
strong b-galactosidase staining in most of the myocardium (see also
Fig. 3C). Labeling is stronger in the left ventricle (LV) than in the
right (RV), where negative tissue is present in the upper region.
Both atria (A) are strongly labeled. A similar pattern is seen with
most T4 transgenic lines. (B) One T4 transgenic line provides an
extreme example of nonuniform nlacZ expression in the adult
heart. LV, left ventricle; RV, right ventricle; LA, left atrium; RA,
right atrium; L, lung. (C) The heart of a 10.5-d.p.c. embryo, from
the same T4 transgenic line shown in B, demonstrates that this
heterogeneity precedes ventricular septation, as shown by b-galac-
tosidase staining which is higher in the putative left ventricle (LV)
than in the areas which will form the right ventricle (RV) and
out¯ow tract (OT).
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et al., 1992) and in cardiocytes derived from the embryonal 1976), a derivative of primary cultures of ventricular cardio-
cytes.carcinoma P19 cell line (Skerjanc and McBurney, 1994), al-
though in both cases the heart cells do not have an adult The distal enhancer is probably also active in some vascu-
lar smooth muscle cells, since expression in blood vesselsphenotype. One possible explanation for the lack of expres-
sion of the mouse transgenes in the adult heart is the pres- is clearly seen with the T4 and T2 transgenes, but not the
T1 and T3 constructs. Although some of the human cardiacence of an additional GATA binding site at 0332/0341 in
the human cardiac actin promoter (see Molkentin et al., actin transgenic mice also express the transgene in some
blood vessels, expression of the endogenous gene has not1994), absent from the mouse promoter. GATA-4 has been
shown to regulate cardiac-speci®c expression of a myosin been reported in vascular tissue. This may have gone unde-
tected since the coronary vessels which express the nlacZheavy chain (Molkentin et al., 1994), cardiac troponin C (Ip
et al., 1994), and atrial natriuretic factor (ANF) (GreÂpin et transgene strongly are surrounded by myocardium which
expresses high levels of the endogenous gene. Expressional., 1994) genes, and this site may be critical for the level
of expression of the cardiac actin transgene. Skeletal muscle elsewhere is detected in a subset of vessels which could
have been missed by in situ hybridization, particularly ifregulation of the human cardiac actin transgene is also dif-
ferent in the adult. No down-regulation is seen with the transcription is low. The presence of cardiac actin in the
vasculature of the lung would not be altogether unexpectedproximal promoter fragment of the human gene, whereas
this is observed when a 3* ¯anking sequence is present in since this tissue, the so-called pulmonary myocardium, has
been shown to express a number of striated muscle genes,the transgene (Dunwoodie et al., 1994). This sequence
(/6.2//7.3 kb) has a clear effect on mRNA accumulation notably genes also transcribed in the adult atria (Jones et
al., 1994). However, given the lack of activity of the distaland, as the authors suggest, may act via a posttranscrip-
tional mechanism. Transcriptional run-on experiments enhancer in the heart, it is unlikely that the same regulatory
element is involved. The question of smooth versus striatedwith nuclei prepared from fetal and neonatal skeletal mus-
cle tissues suggest that cardiac actin transcription, relative muscle regulation is interesting in the context of the evolu-
tion of different a-actin genes from a common ancestorto that of skeletal actin, is lower after birth (Cox and Buck-
ingham, 1992). The results presented here demonstrate that, (Vandekerckhove and Weber, 1984). It is quite possible that
the a-cardiac actin gene shares a regulatory element in theat least for the mouse gene, there is a transcriptional level
of control, mediated via the proximal promoter. We can distal enhancer with the a-smooth actin gene, and that in
the mouse a-cardiac actin locus this element is normallyexclude the possibility that the nlacZ reporter gene se-
quence is responsible, since a similar reporter gene shows masked.
high-level expression in adult skeletal muscle with myosin
(Kelly et al., 1995) regulatory elements. These apparent dif-
The Cardiac Muscle Enhancer, Alone and inferences between the human and mouse cardiac actin genes
Conjunction with the Distal Enhancermay be partly due to the fact that several regulatory mecha-
nisms are operating together, but they also underscore the Comparison of T3 and T1 mice shows that the T3 con-
struct contains an element which will reproducibly directpotential importance of species-speci®c regulation of gene
expression; such divergence is particularly striking in the transcription of the proximal promoter in skeletal and car-
diac muscle cells in the embryo. Experiments in cell culturecase of such a highly conserved sequence as cardiac actin.
had already shown that an element lying between 05.4 and
03.5 kb enhances expression of the proximal promoter in
differentiated skeletal muscle cells (Biben et al., 1994). TheThe Distal Skeletal Muscle Enhancer
fact that a number of lines (5/11) do not express the
transgene suggests that this proximal enhancer is more sub-Most of the mice carrying the T2 transgene have b-galac-
tosidase activity in embryonic skeletal muscle (four inde- ject to integration site effects than the distal element. In-
deed, when the distal enhancer is also present in the T4pendent integration sites of ®ve, see table in Fig. 1). When
compared to the score with the T1 transgene, it is clear that transgene, 6/6 lines express nlacZ in embryonic skeletal
and cardiac muscle and in the adult heart, reproducing thethe presence of the distal enhancer is suf®cient to activate
transcription of the proximal promoter in skeletal muscle. expression of the endogenous gene. The distal enhancer re-
lieves position-dependent constraints and in this sense actsHowever, very little labeling is seen in the embryonic heart
and virtually none in the adult. The absence of activity in as a locus control region element. Unlike the distal en-
hancer in T2 mice, sequences in the T3 transgene also directthe heart shows that the enhancer is inactive in the myocar-
dium, except perhaps in rare cell lineages. The result is b-galactosidase activity throughout the embryonic heart,
and this is maintained in the adult. The possibility that theconsistent with observations on cultured muscle cells
which showed that activity of the distal enhancer depends distal enhancer may function as a cardiac silencing element,
at least in the embryo, arises because the two expressingon an E-box which binds myogenic factors of the MyoD
family (Biben et al., 1994) absent in cardiac cells (see Buck- lines which contain only the proximal promoter show b-
galactosidase staining in the embryonic heart. However theingham, 1994) and that it is inactive (C. Biben, unpublished
observations) in the H9 rat cell line (Kimes and Brandt, T4 transgene which contains the distal enhancer consis-
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tently expresses throughout the heart, and furthermore b- is therefore unlikely to re¯ect a physiological response of
the different chambers of the heart to different haemody-galactosidase staining in the adult heart is only seen in T3
and T4 lines, leading to the conclusion that a positive car- namic loads. These transgenic mice may therefore provide
a useful tool for examining the origin of cells which popu-diac regulatory element is present in these transgenes.
Whether it is the proximal enhancer itself which is respon- late the left and right ventricles. Indeed in cases where the
transgene is only expressed in a few patchy locations in thesible is under investigation.
Interestingly T3, but not T4 mice have an ectopic nlacZ embryonic heart (e.g., Fig. 2 with T1 or T2) the potentially
distinct clonal origin of these myocardial cells can also nowexpression in blood cells. The GATA-4 transcription factor
has been shown to regulate gene expression in the heart be explored.
(e.g., GreÂpin et al., 1994), whereas other members of the
GATA family are potent regulators of hematopoiesis. It re-
Regulation of Genes in Cardiac versus Skeletalmains to be shown whether the cardiac enhancer is regu-
Musclelated via a GATA site, if this is the case it is possible that
in the T3 transgene, unlike the endogenous gene or the T4 For genes expressed in both striated muscle types, there
is already some indication that distinct cardiac and skeletaltransgene, this site is more accessible to transactivation by
other members of the GATA family. regulatory elements may be active in vivo. The mouse M-
phosphocreatine kinase gene is regulated by a complex set
of cis-acting sequences (Johnson et al., 1989) including an
Left/Right Transcriptional Heterogeneity in the upstream region located between 03300 and01256 bp from
Heart the cap site, which appears to be implicated in the enhance-
ment of cardiac rather than skeletal muscle expression, andAlthough the proximal enhancer directs transgene expres-
sion to the adult heart, b-galactosidase staining is nonuni- an intronic enhancer which activates expression in skeletal,
but not cardiac muscle. The MCK enhancer present be-form; the right ventricle is always less labeled than the
left with the T3 and T4 constructs. Reverse transcriptase tween 01256 and 01049 bp which has been the subject of
many in vitro studies increases CAT reporter gene activity,polymerase chain reactions with RNA samples from the
right and left atria and ventricles indicate that the gene is in transgenic mice, in both types of striated muscle. How-
ever, in DNA injection experiments, the equivalent en-evenly expressed in the myocardium (S. Alonso, personal
communication), as do in situ hybridization experiments hancer from the rabbit MCK gene was inactive in the heart,
whereas it enhanced expression of the CAT reporter gene(see Garner et al., 1989). The phenomenon is not only seen
in the adult heart and is already detectable in the embryo. in skeletal muscle (Vincent et al., 1993). An extensive
transgenic analysis of a human gene encoding another meta-It is also seen with the transgenic line T1 where there is
virtually no expression in the adult heart. This would sug- bolic enzyme, aldolase A, where expression in skeletal mus-
cle, heart, and nonmuscle tissues is shown to be regulatedgest that the regulatory sequences which respond to cardiac
signals leading to nonuniform distribution are present in by different promoters, also points to the presence of a dis-
tinct skeletal muscle speci®c enhancer sequence (Con-the T1 construct. The lacZ reporter itself is unlikely to
be responsible, since the human myoglobin promoter±lacZ cordet et al., 1993). In the case of other muscle transgenes
it is more by default that one can conclude that distincttransgene does not show this phenomenon (Parsons et al.,
1993) in adult mouse hearts. We have, however, obtained a elements must exist. A luciferase reporter gene under the
control of 02 kb of upstream sequence from the slow/ven-similar result with a myosin light chain (MLC3F) nlacZ
transgene where we have shown that the enzyme activity tricular myosin light chain, MLC2V/S, gene is expressed in
the heart, but not in slow skeletal muscle (Lee et al., 1992),re¯ects the accumulation of b-galactosidase mRNA (Kelly
et al., 1995), pointing to a transcriptional regulation. Re- whereas 1 kb of 5* ¯anking sequence from the desmin gene
directs expression to skeletal muscle, but not to the heartgional speci®city of a slow/ventricular myosin light chain
MLC2V/S luciferase transgene has also been reported in the where the endogenous gene is also expressed (Li et al., 1993).
In other transgenic experiments, the sequences used di-adult mouse heart with higher expression in the left ventri-
cle (Lee et al., 1992). We have not yet investigated more rected expression to both types of striated muscle in vivo
(e.g., myoglobin, Parsons et al., 1993). Two classes of tran-closely the sequence element(s) implicated in the left/right
modulation of the cardiac actin transgene. Either additional scription factors important in one and not the other striated
muscle type are clearly identi®ed at present, namely, thesequences, necessary for right ventricular expression, are
missing from the transgene or sequences present in the MyoD family in skeletal muscle (Weintraub et al., 1991)
and the GATA-4 factor in cardiac muscle (e.g., GreÂpin ettransgene which respond to differences in left/right regula-
tory signals are masked in the endogenous gene. The phe- al., 1994). Injection of GATA-4 into the skeletal muscle of
the tongue will induce expression of a cardiac a-myosinnomenon itself is also of potential interest in the context
of lineage analysis in the early heart. Although it is dif®cult heavy chain gene construct (Molkentin et al., 1994) and
conversely expression of MyoD in the heart of transgenicto exclude the in¯uence of possible early differences in local
environment, the nonuniform distribution is clearly seen mice induced some skeletal muscle gene expression (Miner
et al., 1992). From the results reported here and those dis-well before cardiac septation is complete in the embryo and
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of the myosin alkali light chain gene in primary muscle cellcussed, it is clear that distinct cardiac and skeletal regula-
cultures: Comparison with other muscle gene promoters andtory elements exist. The presence, in the mouse cardiac
other culture systems. Nucleic Acids Res. 16, 1251±1272.actin gene, of a weak striated muscle promoter which is
Dunwoodie, S. L., Joya, J. E., Arkell, R. M., and Hardeman, E. C.activated by cardiac and skeletal upstream enhancer se-
(1994). Multiple regions of the human cardiac actin gene are nec-quences provides a model for the regulation of a gene ex-
essary for maturation-based expression in striated muscle. J. Biol.
pressed in both striated muscles. In the context of biomedi- Chem. 269, 12212±12219.
cal applications, the in vivo de®nition of such skeletal or Garner, I., Minty, A. J., Alonso, S., Barton, P. J., and Buckingham,
cardiac speci®c enhancer elements is of potential impor- M. E. (1986). A 5* duplication of the a-cardiac actin gene in BALB/
tance, for example, in targeting expression of a sequence to c mice is associated with abnormal levels of a-cardiac and a-
the adult heart. skeletal actin mRNAs in adult cardiac tissue. EMBO J. 5, 2559±
2567.
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